Acorda Therapeutics
ACOR
#10011
Rank
NZ$1.37 M
Marketcap
$1.11
Share price
0.00%
Change (1 day)
-95.70%
Change (1 year)

EPS for Acorda Therapeutics (ACOR)

EPS in 2023 (TTM): -$17.60

According to Acorda Therapeutics 's latest financial reports the company's current EPS (TTM) is -$16.37. In 2022 the company made an earnings per share (EPS) of -$147.67 an increase over its 2021 EPS that were of -$334.19.

EPS history for Acorda Therapeutics from 2006 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$17.60-88.08%
2022-$147.67-55.81%
2021-$334.19-16.13%
2020-$398.48-65.51%
2019-$1,155-898.61%
2018$144.66-114.88%
2017-$972.43536.84%
2016-$152.70-392.31%
2015$52.24-39.53%
2014$86.394.88%
2013$82.38-89.54%
2012$787.59409.09%
2011$154.71-333.33%
2010-$66.30-85.14%
2009-$446.031.37%
2008-$440.0151.03%
2007-$291.33-68.27%
2006-$918.18

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$3.50-121.38%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.30-107.96%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.32-91.92%๐Ÿ‡ฉ๐Ÿ‡ช Germany
-$13.11-19.92%๐Ÿ‡บ๐Ÿ‡ธ USA